Document:

exv10w1

Exhibit 10.1

SUPERCONDUCTOR TECHNOLOGIES INC.

PLACEMENT AGENT AGREEMENT

May 27, 2008

MDB Capital Group, LLC

401 Wilshire Boulevard, Suite 1020

Santa Monica, California 90401

Ladies and Gentlemen:

     Pursuant to the terms of the Common Stock Purchase Agreements in the form of Exhibit A
attached hereto (the “Purchase Agreements”), Superconductor Technologies Inc., a Delaware
corporation (the “Company”), proposes to sell to the Purchasers identified therein (each a
“Purchaser” and, collectively, the “Purchasers”), an aggregate of 2,000,000 shares of Common Stock,
$0.001 par value (the “Common Stock”), of the Company. The aggregate of 2,000,000 shares so
proposed to be sold is hereinafter referred to as the “Shares”. Any capitalized terms not defined
herein shall be as defined in the Purchase Agreement. Pursuant to this Placement Agent Agreement
(this “Agreement”), the Company hereby confirms its agreement with MDB Capital Group LLC (“MDB”) as
follows:

     1. Agreement to Act as Placement Agent; Placement of Securities. On the basis of the
representations, warranties and agreements of the Company herein contained, and subject to all the
terms and conditions of this Agreement:

     (a) The Company hereby authorizes MDB to act as its exclusive agent (in such capacity, the
“Placement Agent”) to solicit offers for the purchase of all or part of the Shares from the Company
in connection with the proposed public offering of the Shares (the “Offering”). Until June 6, 2008,
the Company shall not, without the prior consent of the Placement Agent, solicit or accept offers
to purchase Shares otherwise than through the Placement Agent.

     (b) The Placement Agent shall make commercially reasonable efforts to assist the Company in
obtaining performance by each Purchaser whose offer to purchase Shares has been solicited by the
Placement Agent and accepted by the Company, but the Placement Agent shall not, except as otherwise
provided in this Agreement, be obligated to disclose the identity of any potential purchaser or
have any liability to the Company in the event any such purchase is not consummated for any reason.
Under no circumstances will the Placement Agent be obligated to purchase any Shares for its own
account and, in soliciting purchases of Shares, the Placement Agent shall act solely as the
Company’s agent and not as principal.

     (c) The Company shall have the sole right to accept offers to purchase the Shares and may
reject any such offer, in whole or in part. The Placement Agent shall have the right, in its
discretion reasonably exercised, without notice to the Company, to reject any offer to purchase
Shares received by it, in whole or in part, and any such rejection shall not be deemed a breach of
its agreement contained herein.

     (d) The purchases of the Shares by the Purchasers shall be evidenced by the execution of the
Purchase Agreements.

 

     (e) As compensation for services rendered, on each Closing Date the Company shall pay to the
Placement Agent by wire transfer of immediately available funds to an account or accounts
designated by the Placement Agent, an amount equal to six percent (6%) of the gross proceeds
received by the Company from the sale of the Shares on such Closing Date.

     (f) No Shares which the Company has agreed to sell pursuant to the Purchase Agreement shall be
deemed to have been purchased and paid for, or sold by the Company, until such Shares shall have
been delivered to the Purchaser thereof against payment by such Purchaser. If the Company shall
default in its obligations to deliver Shares to a Purchaser whose offer it has accepted, the
Company shall indemnify and hold the Placement Agent harmless against any loss, claim or damage
arising from or as a result of such default by the Company.

     (g) The Placement Agent shall make reasonable efforts to obtain a communication from the
Financial Industry Regulatory Authority (“FINRA”) indicating that FINRA shall have raised no
objection to the fairness and reasonableness of the placement agent terms and arrangements.

     2. The Closing. The time and date of closing and delivery of the documents required
to be delivered to the Placement Agent will be as set forth in the Purchase Agreement.

     3. Representations and Warranties of the Company. The Company hereby makes the same
representations and warranties to the Placement Agent as those made to the Purchasers under the
Purchase Agreements.

     4. Representations and Warranties of the Placement Agent. The Placement Agent hereby
represents and warrants to the Company that it has all necessary licenses to act as Placement Agent
hereunder.

     5. Covenants of the Company. The Company hereby agrees with the Placement Agent that:

          (a) The Company consents to the use by the Placement Agent of the Registration Statement and
Prospectus and any issuer free writing prospectus or any amendment or supplement thereto and any
issuer information used or referred to in any free writing prospectus, as defined in Rule 405 under
the Act, in connection with the Offering.

          (b) The Company will make “generally available” (as such term is described in Rule 158(b) of
the Act) to its security holders and to the Placement Agent as soon as practicable, but in any
event not later than twelve months after the effective date of the Registration Statement (as
defined in Rule 158(c) under the Act), an earnings statement of the Company and the Subsidiaries
which need not be audited, complying with Section 11(a) of the Act (including, at the option of the
Company, Rule 158 under the Act).

          (c) To take all action required by the Company and its counsel in connection with the
qualification of the Shares under the securities or Blue Sky laws of such jurisdictions as the
Placement Agent may request and continue such qualification in effect so long as reasonably
required.

          (d) Whether or not the Offering or any of the transactions contemplated in this Agreement or
the Registration Statement and Prospectus are consummated or this Agreement is terminated, to pay
(i) all costs, expenses, fees and taxes incidental to and in connection with: (A) the preparing,
printing, filing and distributing of the Registration Statement, any Preliminary Prospectus, the
Prospectus and any Issuer Free Writing Prospectus and all amendments and supplements thereto
(including, without limitation, financial statements and exhibits), and all other agreements,
memoranda,

2

 

correspondence and other documents prepared and delivered in connection herewith, (B)
negotiating, printing, processing and distributing (including, without limitation, word processing
and duplication costs) and delivering, each of the Preliminary Prospectus, the Prospectus and any
Issuer Free Writing Prospectus and all amendments and supplements thereto (including, without
limitation, financial statements and exhibits), and all other agreements, memoranda, correspondence
and other documents prepared and delivered in connection herewith, (C) the preparing, issuing and
delivering the Shares, (D) qualifying the Shares for offer and sale under the securities or Blue
Sky laws of the several states and (E) furnishing such copies of the Registration Statement, any
Preliminary Prospectus and the Prospectus, and all amendments and supplements thereto, as may
reasonably be requested for use by the Placement Agent, (ii) all reasonable fees and expenses of
the counsel, accountants and any other experts or advisors retained by the Company, (iii) all fees
and expenses (including reasonable fees and expenses of counsel) of the Company in connection with
approval of the Shares by the Depository Trust Company for “book-entry” transfer, (iv) any listing
fees of the Shares on the NASDAQ Stock Market, (v) the registration, issue, sale and delivery of
the Shares including any stock or transfer taxes and stamp or similar duties payable upon the sale,
issuance or delivery of the Shares to the Placement Agent, (vi) all fees, disbursements and
out-of-pocket expenses incurred by the Placement Agent in connection with its services to be
rendered hereunder including, without limitation, reasonable travel and lodging expenses,
reasonable expenses associated with the production of road show slides and graphics, fees and
expenses of any consultants engaged in connection with the road show presentations, travel, lodging
and other expenses incurred by any such consultants, word processing charges, messenger and
duplicating services, facsimile expenses and other customary expenditures, including reasonable
legal fees, (vii) the fees of the Financial Industry Regulatory Authority (“FINRA”) in connection
with its review of the Offering, and (viii) all other costs and expenses incident to the
performance by the Company of its obligations hereunder. The Placement Agent will not incur any
costs to be reimbursed hereunder without the prior written consent of the Company; provided, at
Closing, the Company shall reimburse the Placement Agent’s reasonable legal fees and expenses
incurred by it in connection with the offering contemplated hereby and in connection with all
previously contemplated offerings in which the Placement Agent was retained on behalf of the
Company, up to a maximum aggregate of $30,000; provided, further, that such reimbursement payment
will fully satisfy all obligations of the Company to reimburse the Placement Agent’s legal fees
through and including the Closing, whether in connection with the offering contemplated hereby or
any such previously contemplated offerings, including pursuant to any letter of intent between the
Placement Agent and the Company.

          (e) Not to, and to ensure that no “affiliate” (as defined in Rule 501(b) of the Act) of the
Company will, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of
any “security” (as defined in the Act) that would be integrated with the sale of the Shares and
cause a violation of federal securities laws.

          (f) Not to, and not to authorize or permit any person acting on its behalf to, distribute any
offering material in connection with the offer and sale of the Shares other than the Registration
Statement, any Issuer Free Writing Prospectus permitted to be distributed and the Prospectus and
any amendments and supplements thereto or to the Registration Statement and the Prospectus prepared
in compliance with this Agreement.

          (g) The Company will not take and will cause its controlled affiliates (within the meaning of
Rule 144 under the Act) not to take, directly or indirectly, any action designed to or which has
constituted or which might reasonably be expected to cause or result, under the 1934 Act or
otherwise, in stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Shares in violation of applicable law.

3

 

          (h) To pay all stamp, documentary and transfer taxes and other duties, if any, which may be
imposed by the United States or any political subdivision thereof or taxing authority thereof or
therein with respect to the issuance of the Shares or the sale thereof to the subscribers.

     6. Mutual Covenants. The Company agrees that, unless it obtains the prior written
consent of the Placement Agent, and the Placement Agent agrees with the Company that, unless it has
obtained or will obtain, as the case may be, the prior written consent of the Company, it has not
made and will not make any offer relating to the Shares that would constitute an Issuer Free
Writing Prospectus or that would otherwise constitute a Free Writing Prospectus required to be
filed by the Company with the Commission or retained by the Company under Rule 433 under the Act.
Any such free writing prospectus consented to by the Placement Agent or the Company is hereinafter
referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (x) it has treated
and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free
Writing Prospectus and (y) it has complied and will comply, as the case may be, with the
requirements of Rules 164 and 433 under the Act applicable to any Permitted Free Writing
Prospectus, including in respect of timely filing with the Commission, legending and record
keeping. If at any time after the date hereof any events shall have occurred as a result of which
any Issuer Free Writing Prospectus, as then amended and supplemented, would conflict with the
information in the Registration Statement, the Prospectus or would include an untrue statement of a
material fact or omit to state any material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading, or, if for any other
reason it shall be necessary to amend or supplement any Issuer Free Writing Prospectus, the Company
agrees to notify the Placement Agent and, upon the Placement Agent’s request, to file such document
and prepare and furnish without charge to the Placement Agent as many copies as the Placement Agent
may from time to time reasonably request of an amended or supplemented Issuer Free Writing
Prospectus that will correct such conflict, statement or omission or effect such compliance.

     7. Indemnification and Contribution.

          (a) The Company agrees to indemnify and hold harmless the Placement Agent, and each person, if
any, who controls the Placement Agent within the meaning of Section 15 of the Act or Section 20 of
the 1934 Act, against any losses, claims, damages or liabilities of any kind to which, jointly or
severally, the Placement Agent or such controlling person may become subject under the Act, the
1934 Act or otherwise, insofar as any such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue
statement of any material fact contained in (A) the Registration Statement, the Prospectus or any
Issuer Free Writing Prospectus, or in any amendment thereof or supplement thereto, (B) any “issuer
information” used or referred to in any “free writing prospectus” (as defined in Rule 405 under the
Act) used or referred to by the Placement Agent, or (C) any blue sky application or other document
prepared or executed by the Company (or based upon an written information furnished by the Company)
specifically for the purpose of qualifying any or all of the Shares under the securities laws of
any state or other jurisdiction (any such application, document or information being hereinafter
called a “Blue Sky Application” and the documents referred to in subclauses (A), (B) and (C) hereof
being referred to collectively as the “Indemnity Documents”); or (ii) the omission or alleged
omission to state in any of the Indemnity Documents a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading, including any losses, claims, damages or liabilities arising out of or based
upon the Company’s failure to perform its obligations under the Purchase Agreements, and, subject
to the provisions hereof, will reimburse, as incurred, the Placement Agent and each such
controlling person for any legal or other expenses reasonably incurred by the Placement Agent or
such controlling person in connection with investigating, defending against or appearing as a
third-party witness in connection with any such loss, claim, damage, liability or action in respect
thereof; provided, however, that the Company will not be liable in any such case to the extent (but
only to the extent) that any such loss, claim, damage

4

 

or liability resulted from any untrue statement or alleged untrue statement or omission or
alleged omission made in any of the Indemnity Documents in reliance upon and in conformity with the
Placement Agent Information. This indemnity agreement will be in addition to any liability that the
Company may otherwise have to the indemnified parties.

          (b) The Placement Agent agrees to indemnify and hold harmless each of the Company, and its
respective directors, officers and each person, if any, who controls the Company within the meaning
of Section 15 of the Act or Section 20 of the 1934 Act against any losses, claims, damages or
liabilities of any kind to which the Company or any such director, officer or controlling person
may become subject under the Act, the 1934 Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) resulted from (i) any untrue statement or
alleged untrue statement of any material fact contained in any of the Indemnity Documents, or (ii)
the omission or the alleged omission to state therein a material fact required to be stated in any
of the Indemnity Documents or necessary to make the statements therein not misleading, in each case
to the extent (but only to the extent) that such untrue statement or alleged untrue statement or
omission or alleged omission was made in reliance upon and in conformity with the Placement Agent
Information; and, subject to the limitation set forth immediately preceding this clause, will
reimburse, as incurred, any legal or other expenses incurred by the Company or any of its
directors, officers or controlling persons in connection with any such loss, claim, damage,
liability or action in respect thereof. This indemnity agreement will be in addition to any
liability that the Placement Agent may otherwise have to such indemnified parties.

          (c) As promptly as reasonably practical after receipt by an indemnified party under this
Section 7 of notice of the commencement of any action for which such indemnified party is entitled
to indemnification under this Section 7, such indemnified party will, if a claim in respect thereof
is to be made against the indemnifying party under this Section 7, notify the indemnifying party of
the commencement thereof in writing; but the omission to so notify the indemnifying party (i) will
not relieve such indemnifying party from any liability under paragraph (a) or (b) above unless and
only to the extent it is materially prejudiced as a result thereof and (ii) will not, in any event,
relieve the indemnifying party from any obligations to any indemnified party other than the
indemnification obligation provided in paragraphs (a) and (b) above. In case any such action is
brought against any indemnified party, and it notifies the indemnifying party of the commencement
thereof, the indemnifying party will be entitled to participate therein and, to the extent that it
may determine, jointly with any other indemnifying party similarly notified, to assume the defense
thereof, with counsel reasonably satisfactory to such indemnified party; provided, however, that if
(i) the use of counsel chosen by the indemnifying party to represent the indemnified party would
present such counsel with a conflict of interest, (ii) the defendants in any such action include
both the indemnified party and the indemnifying party, and the indemnified party shall have been
advised by counsel in writing that there may be one or more legal defenses available to it and/or
other indemnified parties that are different from or additional to those available to the
indemnifying party, or (iii) the indemnifying party shall not have employed counsel reasonably
satisfactory to the indemnified party to represent the indemnified party within a reasonable time
after receipt by the indemnifying party of notice of the institution of such action, then, in each
such case, the indemnifying party shall not have the right to direct the defense of such action on
behalf of such indemnified party or parties and such indemnified party or parties shall have the
right to select separate counsel to defend such action on behalf of such indemnified party or
parties at the expense of the indemnifying party. After notice from the indemnifying party to such
indemnified party of its election so to assume the defense thereof and approval by such indemnified
party of counsel appointed to defend such action, the indemnifying party will not be liable to such
indemnified party under this Section 7 for any legal or other expenses, other than reasonable costs
of investigation, subsequently incurred by such indemnified party in connection with the defense
thereof, unless (i) the indemnified party shall have employed separate counsel in accordance with
the proviso to the immediately preceding sentence (it being understood, however, that in connection
with such action the indemnifying party shall not be liable for the

5

 

expenses of more than one separate counsel (in addition to local counsel) in any one action or
separate but substantially similar actions in the same jurisdiction arising out of the same general
allegations or circumstances, designated by the Placement Agent in the case of paragraph (a) of
this Section 7 or the Company in the case of paragraph (b) of this Section 7, representing the
indemnified parties under such paragraph (a) or paragraph (b), as the case may be, who are parties
to such action or actions) or (ii) the indemnifying party has authorized in writing the employment
of counsel for the indemnified party at the expense of the indemnifying party. After such notice
from the indemnifying party to such indemnified party, the indemnifying party will not be liable
for the costs and expenses of any settlement of such action effected by such indemnified party
without the prior written consent of the indemnifying party (which consent shall not be
unreasonably withheld), unless such indemnified party waived in writing its rights under this
Section 7, in which case the indemnified party may effect such a settlement without such consent.

          (d) No indemnifying party shall be liable under this Section 7 for any settlement of any claim
or action (or threatened claim or action) effected without its written consent, which shall not be
unreasonably withheld, but if a claim or action is settled with its written consent, or if there be
a final judgment for the plaintiff with respect to any such claim or action, each indemnifying
party, jointly and severally, agrees, subject to the exceptions and limitations set forth above, to
indemnify and hold harmless each indemnified party from and against any and all losses, claims,
damages or liabilities (and legal and other expenses as set forth above) incurred by reason of such
settlement or judgment. No indemnifying party shall, without the prior written consent of the
indemnified party (which consent shall not be unreasonably withheld), effect any settlement or
compromise of any pending or threatened proceeding in respect of which the indemnified party is or
could have been a party, or indemnity could have been sought hereunder by the indemnified party,
unless such settlement (A) includes an unconditional written release of the indemnified party, in
form and substance satisfactory to the indemnified party, from all liability on claims that are the
subject matter of such proceeding and (B) does not include any statement as to an admission of
fault, culpability or failure to act by or on behalf of the indemnified party.

          (e) In circumstances in which the indemnity agreement provided for in the preceding paragraphs
of this Section 7 is unavailable to, or insufficient to hold harmless, an indemnified party in
respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to
therein, each indemnifying party, in order to provide for just and equitable contributions, shall
contribute to the amount paid or payable by such indemnified party as a result of such losses,
claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate
to reflect (i) the relative benefits received by the indemnifying party or parties, on the one
hand, and the indemnified party, on the other, from the Offering or (ii) if the allocation provided
by the foregoing clause (i) is not permitted by applicable law, not only such relative benefits but
also the relative fault of the indemnifying party or parties, on the one hand, and the indemnified
party, on the other, in connection with the statements or omissions or alleged statements or
omissions that resulted in such losses, claims, damages or liabilities (or actions in respect
thereof). The relative benefits received by the Company, on the one hand, and the Placement Agent,
on the other, shall be deemed to be in the same proportion as the total proceeds from the Offering
(before deducting expenses) received by the Company bear to the total discounts, commissions and
fees received by the Placement Agent. The relative fault of the parties shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to information supplied by the
Company, on the one hand, or the Placement Agent, on the other, the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such statement or omission
or alleged statement or omissions, and any other equitable considerations appropriate in the
circumstances.

6

 

          (f) The Company and the Placement Agent agree that it would not be equitable if the amount of
such contribution determined pursuant to the immediately preceding paragraph (e) were determined by
pro rata or per capita allocation or by any other method of allocation that does not take into
account the equitable considerations referred to in the first sentence of the immediately preceding
paragraph (e). Notwithstanding any other provision of this Section 7, the Placement Agent shall not
be obligated to make contributions hereunder, or make any other payments under this Section 7, that
in the aggregate exceed the total discounts, commissions, fees and other compensation received by
such Placement Agent under this Agreement less the aggregate amount of any damages that such
Placement Agent has otherwise been required to pay by reason of the untrue or alleged untrue
statements or the omissions or alleged omissions to state a material fact. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes
of the immediately preceding paragraph (e), each person, if any, who controls the Placement Agent
within the meaning of Section 15 of the Act or Section 20 of the 1934 Act shall have the same
rights to contribution as the Placement Agent, and each director and officer of the Company and
each person, if any, who controls the Company within the meaning of Section 15 of the Act or
Section 20 of the 1934 Act, shall have the same rights to contribution as the Company.

     8. Successors; Persons Entitled To Benefit Of Agreement. This Agreement shall inure
to the benefit of and be binding upon the Placement Agent, the Company, and their respective
successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to
give any person other than the persons mentioned in the preceding sentence any legal or equitable
right, remedy or claim under or in respect of this Agreement, or any provisions herein contained,
this Agreement and all conditions and provisions hereof being intended to be and being for the sole
and exclusive benefit of such persons and for the benefit of no other person; except that the
representations, warranties, covenants, agreements and indemnities of the Company contained in this
Agreement shall also be for the benefit of the Placement Agent Indemnified Parties and the
indemnities of the Placement Agent shall also be for the benefit of the Company Indemnified
Parties. It is understood that the Placement Agent’s responsibilities to the Company are solely
contractual in nature and the Placement Agent does not owe the Company, or any other party, any
fiduciary duty as a result of this Agreement.

     9. Survival Of Indemnities, Representations, Warranties, Etc. The respective
indemnities, covenants, agreements, representations, warranties and other statements of the Company
and the Placement Agent, as set forth in this Agreement or made by them respectively, pursuant to
this Agreement, shall remain in full force and effect, regardless of any investigation made by or
on behalf of the Placement Agent, the Company, or any person controlling any of them and shall
survive delivery of and payment for the Shares.

     10. Information Supplied by the Placement Agent. The name of the Placement Agent set
forth on the front and back cover and the information within the heading “Plan of Distribution” in
the Prospectus (to the extent such statements relate to the Placement Agent) (the “Placement Agent
Information”) constitute the only information furnished by such Placement Agent as to itself to the
Company for the purposes hereof.

     11. Miscellaneous.

          (a) THE VALIDITY AND INTERPRETATION OF THIS AGREEMENT, AND THE TERMS AND CONDITIONS SET FORTH
HEREIN SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA
APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED WHOLLY THEREIN, WITHOUT REGARD TO PRINCIPLES OF
CONFLICTS OF LAW.

7

 

          (b) EACH OF THE COMPANY HEREBY EXPRESSLY AND IRREVOCABLY (I) SUBMITS TO THE NON-EXCLUSIVE
JURISDICTION OF THE FEDERAL AND STATE COURTS SITTING IN THE COUNTY OF LOS ANGELES, STATE OF
CALIFORNIA IN ANY SUIT OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY; AND (II) WAIVES (A) ITS RIGHT TO A TRIAL BY JURY IN ANY LEGAL
ACTION OR PROCEEDING RELATING TO THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREBY, OR ANY
COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF THE
PLACEMENT AGENT AND FOR ANY COUNTERCLAIM RELATED TO ANY OF THE FOREGOING AND (B) ANY OBJECTION
WHICH IT MAY HAVE OR HEREAFTER MAY HAVE TO THE LAYING OF VENUE OF ANY SUCH LITIGATION BROUGHT IN
ANY SUCH COURT REFERRED TO ABOVE AND ANY CLAIM THAT ANY SUCH LITIGATION HAS BEEN BROUGHT IN AN
INCONVENIENT FORUM.

          (c) This Agreement may be signed in various counterparts which together shall constitute one
and the same instrument.

          (d) The headings in this Agreement are for convenience of reference only and shall not limit
or otherwise affect the meaning hereof.

          (e) If any term, provision, covenant or restriction of this Agreement is held by a court of
competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms,
provisions, covenants and restrictions set forth herein shall remain in full force and effect and
shall in no way be affected, impaired or invalidated, and the parties hereto shall use their
commercially reasonable efforts to find and employ an alternative means to achieve the same or
substantially the same result as that contemplated by such term, provision, covenant or
restriction. It is hereby stipulated and declared to be the intention of the parties that they
would have executed the remaining terms, provisions, covenants and restrictions without including
any of such that may be hereafter declared invalid, illegal, void or unenforceable.

          (f) This Agreement may be amended, modified or supplemented, and waivers or consents to
departures from the provisions hereof may be given, provided that the same are in writing and
signed by all of the signatories hereto. This Agreement constitutes the entire agreement of the
parties hereto with respect to the subject matter hereof. This Agreement supersedes in full all
previous oral or written agreements between the parties with respect to the subject matter hereof.
There are no oral or written collateral representations, agreements, or understandings except as
provided herein.

          (g) In the course of its services under this Agreement, the Placement Agent will have access
to Confidential Information (as defined below) concerning the Company. The Placement Agent agrees
that all Confidential Information will be treated by the Placement Agent as confidential in all
respects. The Placement Agent hereby agrees that it and its dealers, affiliates and representatives
shall: (i) use the Confidential Information solely for the purposes of its engagement hereunder;
and (ii) not disclose any Confidential Information to any other party except to those Placement
Agent representatives who need to know such information for the purposes of the Placement Agent’s
engagement hereunder and who have been advised of such confidentiality restrictions. The term
“Confidential Information” shall mean all information, whether written or oral, which is or has
been disclosed by the Company or their respective affiliates, agents or representatives to the
Placement Agent or any of its representatives in connection with the transactions contemplated
hereby, which is not in the public domain, but shall not include: (i) information which is publicly
disclosed other than by the Placement Agent in violation of this Agreement; (ii) information which
is obtained by the Placement Agent from a third party that (x) has not violated, or obtained such
information in violation of, any obligation to the Company or its affiliates with

8

 

respect to such information, and (y) does not require the Placement Agent to refrain from
disclosing such information; and (iii) information which is required to be disclosed by the
Placement Agent or its outside counsel under compulsion of law (whether by oral question,
interrogatory, subpoena, civil investigative demand or otherwise) or by order of any court or
governmental or regulatory body to whose supervisory authority the Placement Agent is subject;
provided that, in such circumstance, the Placement Agent will give the Company
prior written notice promptly following Placement Agent’s knowledge or determination of such
requirement of disclosure and cooperate with the Company to minimize the scope of any such
disclosure. The Placement Agent’s obligation under this section shall continue after the date of
expiration, termination or completion of this Agreement or the Placement Agent’s engagement
hereunder.

9

 

	 	 	 	 	 
	 	Very truly yours,

SUPERCONDUCTOR TECHNOLOGIES INC.

 	 
	 	By:  	/s/ Jeffrey A. Quiram 	 
	 	 	Name:  	Jeffrey A. Quiram 	 
	 	 	President and CEO 	 
	 

ACCEPTED AND AGREED TO AS OF

THE DATE FIRST ABOVE WRITTEN:

MDB CAPITAL GROUP LLC

	 	 	 	 	 
	/s/ Anthony Digiandomenico 	 	 	 
	By:  	Anthony Digiandomenico	 	 	 
	Title:  	Principal	 	 	 

10exv10w2

Exhibit 10.2

COMMON STOCK PURCHASE AGREEMENT

     THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is made as of May 27, 2008 by
and between Superconductor Technologies Inc., a Delaware corporation (the “Company”), and
                     (the “Investor”).

RECITALS

     A. The Company and the Investor desire to enter into this transaction to
purchase and sell the securities set forth herein pursuant to a currently effective shelf
registration statement on Form S-3, which has at least $80,000,000 in unallocated securities
registered thereunder (Registration Number 333-148115) (the “Registration Statement”),
which Registration Statement has been declared effective in accordance with the Securities Act of
1933, as amended, and the rules and regulations promulgated thereunder (the “Act”), by the
United States Securities and Exchange Commission (the “Commission”).

     B. The Investor wishes to purchase from the Company, and the Company wishes to
sell to the Investor, upon the terms and conditions stated in this Agreement, 1,000,000 shares of
common stock, no par value per share, of the Company (the “Common Stock”), at a purchase
price of $3.00 per share.

     NOW, THEREFORE, the Company and the Investor hereby agree as follows:

AGREEMENT

     1. As of the Closing (as defined below) and subject to the terms and conditions
hereof, the Company and the Investor agree that the Investor will purchase from the Company and the
Company will issue and sell to the Investor one million shares of Common Stock (the
“Shares”) for a purchase price of $3.00 per share, or an aggregate purchase price of
$3,000,000 (the “Purchase Price”).

     2. The completion of the purchase and sale of the Shares shall occur at a closing
(the “Closing”) which is expected to occur on May 30, 2007 at or about 8:00 a.m., Los
Angeles time (unless another time or date shall be agreed upon by the Company and the Investor). 
At the Closing, (i) the Investor shall pay its Purchase Price to the Company for the Shares to be
issued and sold to such Investor at the Closing, by wire transfer of immediately available funds in
accordance with the Company’s written wire instructions, and (ii) upon confirmation of receipt of
such wire, unless otherwise requested by the Investor and agreed to by the Company, the Shares
purchased by the Investor will be delivered by electronic book-entry at The Depository Trust
Company (“DTC”), registered in the Investor’s name and address as set forth below, and will
be released by Registrar and Transfer Company, the Company’s transfer agent (the “Transfer
Agent”), to the Investor at the Closing.  After the execution of this Agreement by the
Investor, the Investor shall direct the broker-dealer at which the account or accounts to be
credited with the Shares are maintained to set up a deposit/withdrawal at custodian
(“DWAC”) instructing the Transfer Agent to credit such account or accounts with the
Shares.  The Shares shall be free of restrictive legends.

     3. The Company has delivered to the Investor and shall file with the Commission a
prospectus and prospectus supplement (collectively the “Prospectus”), which form a part of
the Registration Statement, reflecting the offering of the Shares in conformity with the Act,
including Rule 424(b) thereunder.  The Investor agrees that such Prospectus may be delivered to it
in electronic form.

     4. The offering and sale of the Shares are being made pursuant to the Registration
Statement and the Prospectus.  The Investor acknowledges that the Company intends to enter into
agreements with certain other investors on substantially the same form of this Agreement (and at
the same price per share) on or about the date hereof covering (including the Shares being issued
hereunder) up to a total of 2,000,000 shares of Common Stock (the “Offering”) pursuant to
the Registration Statement and the Prospectus. Except for (i) the Offering, and (ii) issuances of
Common Stock (a) to employees, directors and consultants pursuant to grants under the Company’s
equity incentive plan(s), (b) pursuant to currently outstanding warrants, rights and convertible
securities, and (c) for consideration other than cash or cash equivalents, the Company will not
sell any other shares of Common Stock, whether under the Registration Statement or pursuant to
privately negotiated sales, prior to August 30, 2008;

 

 

provided, this sentence shall not restrict issuances of Common Stock on terms more favorable
to the Company than the terms provided for in the Offering.

     5. The Company hereby makes the following representations, warranties and
covenants to the Investor:

          (a) The Company is an entity duly incorporated, validly existing and in good
standing under the laws of the state of Delaware, with the requisite power and authority to own and
use its properties and assets and to carry on its business as currently conducted.  The Company has
the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and otherwise to carry out its obligations hereunder.  The execution
and delivery of this Agreement by the Company and the issuance of the Shares have been duly
authorized by all necessary action on the part of the Company and no further consent or action is
required by the Company, its board of directors or its shareholders.  This Agreement has been (or
upon delivery will be) duly executed by the Company and, when delivered in accordance with the
terms hereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except as may be limited by any bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance or other similar laws affecting the enforcement
of creditors’ rights generally or by general principles of equity.

          (b) The execution, delivery and performance of this Agreement by the Company and the
consummation by the Company of the transactions contemplated hereby do not and will not (i)
conflict with or violate any provision of the Company’s articles of incorporation or bylaws, (ii)
subject to obtaining the Required Approvals (as defined below), conflict with, or constitute a
default (or an event that with notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company debt or otherwise) or other understanding to which the Company is a party or
by which any property or asset of the Company is bound or affected, or (iii) result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court
or governmental authority to which the Company is subject (including federal and state securities
laws and regulations) and the rules and regulations of any self-regulatory organization to which
the Company or its securities are subject, or by which any property or asset of the Company is
bound or affected except in each case of clause (ii) or (iii) such as would not, individually or in
the aggregate, have a except have a material adverse effect on the business, properties, financial
condition or results of operations of the Company as set forth in the Registration Statement and
the Prospectus (exclusive of any amendments or supplements thereto subsequent to the Closing date)
or materially impair the Company’s ability to perform its obligations under this Agreement (a
“Material Adverse Effect”).

          (c) The Company is not required to obtain any consent, waiver, authorization or
order of, give any notice to, or make any filing or registration with, any court or other federal,
state, local or other governmental authority or other Person in connection with the execution,
delivery and performance by the Company of this Agreement, other than (i) the required filing of
the Prospectus and the Registration Statement, (ii) applicable state securities law filings, (iii)
the required filings with The Nasdaq Stock Market (the “Trading Market”), and (iv) in all
other cases, where the failure to obtain such consent, waiver, authorization or order, or to give
such notice or make such filing or registration would  not have a Material Adverse Effect (clauses
(i), (ii) and (iii) collectively, the “Required Approvals”).  The Company has obtained all
the Required Approvals, except for those which will be obtained in the ordinary course prior to the
Closing.

          (d) The Shares are duly authorized and, when issued and paid for in accordance with
the terms hereof, will be duly and validly issued, fully paid and nonassessable, free and clear of
all liens, encumbrances and rights of first refusal, and conform to the description of Common Stock
contained in the Prospectus.  The Company has reserved a sufficient number of duly authorized
shares of common stock to issue all of the Shares.  At the Closing, the Shares shall have been
approved for quotation on the Trading Market.

          (e) The Registration Statement (including any prospectus and prospectus supplement
and all information or documents incorporated by reference therein) was declared effective by the
Commission on February 13, 2008.  The Registration Statement is effective on the date hereof and no
order preventing or suspending the use of the Registration Statement or any Prospectus has been or
is intended by the Commission to be issued by the Commission.  The term “Registration
Statement” as used in this Agreement means the Registration

 

 

Statement at the time it became effective and as supplemented or amended from time to time,
including all financial schedules and exhibits thereto and all documents incorporated by reference
or deemed to be incorporated by reference therein.  The Registration Statement, as of the time it
was declared effective, and any amendments or supplements thereto as of the effective date thereof,
and any prospectus included therein complied, and the Prospectus complies, as of the applicable
filing date thereof, in all material respects with the requirements of the Act, and none of such
Registration Statement nor any such Prospectus, nor any report, schedule, form or statement filed
by the Company under the Securities Exchange Act of 1934 (the “Exchange Act”) pursuant to
Sections 13(a) or 15(d) thereunder and incorporated into the Prospectus, contains or, at the time
of filing with the Commission contained, any untrue statement of material fact or omits or, at the
time of filing with the Commission, omitted to state any material fact required to be stated
therein or necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading.  The offering, sale and issuance of the Shares to the Investor are
registered under the Act by the Registration Statement, and no action taken or omitted to be taken
by the Company shall cause such Shares not to be freely transferable and tradable by the Investor
without restriction.  The Shares are being issued as described in the Registration Statement.

          (f) The Company has not, in the twelve (12) months preceding the date hereof,
received notice from the Trading Market to the effect that the Company is not in compliance with
the listing or maintenance requirements thereof. The Company is, and has no reason to believe that
it will not in the foreseeable future continue to be, in material compliance with the listing and
maintenance requirements for continued trading of the Common Stock on the Trading Market. The
issuance and sale of the Shares hereunder complies in all material respects with the rules or
regulations of the Trading Market.

          (g) During the 30 days prior to the date hereof, the Company has not, and to its knowledge no
one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to
result in the stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of any of the Common Stock, (ii) sold, bid for, purchased, or, paid
any compensation for soliciting purchases of, any of the Common Stock, or (iii) paid or agreed to
pay to any Person any compensation for soliciting another to purchase any other securities of the
Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company’s
placement agent in connection with the placement of the Common Stock.

          6. The Investor hereby makes the following representations, warranties and covenants
to the Company:

          (a) The Investor is purchasing the Shares for its own account, in the ordinary
course of its business and the Investor has no arrangement with any Person to participate in the
distribution of the Shares.  The Investor represents that it has received the Prospectus prior to
or in connection with its receipt of this Agreement.  In connection with its decision to purchase
the Shares, the Investor has relied only upon the Prospectus and the documents incorporated by
reference therein, and the representations and warranties of the Company contained herein.

          (b) The Investor, together with its affiliates (as that term is defined under Rule
405 of the Act), has not, prior to the date of this Agreement, sold, offered to sell, solicited
offers to buy, disposed of, loaned, pledged or granted any right with respect to (collectively, a
“Disposition”), the Shares purchased in the Offering.  Such prohibited sales or other transactions
would include, without limitation, effecting any short sale or having in effect any short position
(whether or not such sale or position is against the box and regardless of when such position was
entered into) or any purchase, sale or grant of any right (including, without limitation, any put
or call option) with respect to the Shares purchased in the offering made by the Prospectus.

          (c) The Investor shall not issue any press release or make any other public
announcement relating to this Agreement unless (i) the content thereof is mutually agreed to by the
Company and the Investor, or (ii) the Investor is advised by its counsel that such press release or
public announcement is required by law.  The Investor will timely make all required filings and
disclosures relating to the Investor’s purchase of the Shares as may be required under the Exchange
Act, if any.

 

 

          (d) The Investor has the requisite power and authority to enter into and to
consummate the transactions contemplated by this Agreement and otherwise to carry out its
obligations hereunder.  The execution and delivery of this Agreement by the Investor and the
consummation by it of the transactions contemplated hereunder have been duly authorized by all
necessary action on the part of the Investor.  This Agreement has been duly executed by the
Investor and, when delivered in accordance with the terms hereof, will constitute the valid and
binding obligation of the Investor enforceable against the Investor in accordance with its terms,
except as may be limited by any bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance or other similar laws affecting the enforcement of creditors’ rights generally or by
general principles of equity.

          (e) The Investor understands that nothing in this Agreement or any other materials
presented to the Investor in connection with the purchase or sale of the Shares constitutes legal,
tax or investment advice.  The Investor has consulted such legal, tax or investment advisors as it,
in its sole discretion, deems necessary or appropriate in connection with its purchase of the
Shares.

          (f) The Investor hereby acknowledges that it is acting independently from any other
investor (and has engaged separate legal counsel) in connection with the Offering, and that it is
not acting as a member of a “group” (as such term is defined in Rule 13d of the Exchange Act) with
any other investor in connection with the Offering.

          (g) The Investor hereby acknowledges that the Company will pay a commission to MDB Capital
Group LLC of 6% of the gross proceeds of the Offering.

     7. Subject to the provisions of this Section 7, the Company will indemnify and
hold the Investor and its directors, officers, shareholders, partners, members, employees and
agents (each, an “Investor Party”) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any
such Investor Party may suffer or incur (the “Indemnified Liabilities”) as a result of or
relating to any breach of any of the representations, warranties, covenants or agreements made by
the Company in this Agreement.  The Company shall not be liable to any Investor under this
provision in respect of any Indemnified Liability if such liability arises out of any
misrepresentation by the Investor in Section 6 of this Agreement or actions taken by such Investor
otherwise than as explicitly set forth herein.  To the extent that the foregoing undertaking by the
Company may be unenforceable for any reason, the Company shall make the maximum contribution to the
payment and satisfaction of each of the Indemnified Liabilities which is permissible under
applicable law.  If any action shall be brought against any Investor Party in respect of which
indemnity may be sought pursuant to this Agreement, such Investor Party shall promptly notify the
Company in writing, and the Company shall have the right to assume the defense thereof with counsel
of its own choosing.  Any Investor Party shall have the right to employ separate counsel in any
such action and participate in the defense thereof (it being understood, however, that the Company
shall not be liable for the expenses of more than one separate counsel (other than local counsel),
reasonably approved by the Company), but the fees and expenses of such counsel shall be at the
expense of such Investor Party except to the extent that (i) the employment thereof has been
specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in
the reasonable opinion of such separate counsel, a material conflict on any material issue between
the position of the Company and the position of such Investor Party.  The Company will not be
liable to any Investor Party under this Section 7 for any settlement by an Investor Party effected
without the Company’s prior written consent, which shall not be unreasonably withheld or delayed.

     8. The Company shall, by 9:00 a.m. (New York City time) on the day immediately
following the date hereof, issue a press release, disclosing the material terms of the transactions
contemplated hereby.

     9. This Agreement shall be governed by, and construed in accordance with, the internal laws of
the State of Delaware, without giving effect to the principles of conflicts of law.10. The Company
confirms that its has not provided Investor, in the course of its review of the Company, with any
information that the Company believes constitutes material non-public information.

 

 

     11. This Agreement may be executed in two or more counterparts, each of which shall
constitute an original, but all of which, when taken together, shall constitute but one instrument,
and shall become effective when one or more counterparts have been signed by each party hereto and
delivered to the other parties.

 

 

[SIGNATURE PAGE TO COMMON STOCK PURCHASE AGREEMENT WITH SUPERCONDUCTOR

TECHNOLOGIES INC., DATED MAY 27, 2008]

                     IN WITNESS WHEREOF, the Investor and the Company have caused this Common Stock
Purchase Agreement to be duly executed as of the date first written above.

 

	 	 	 	 	 	 	 	 	 	 	 
	Superconductor Technologies Inc.	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	By:

	 	 	 	 	 	By:	 	 	 	 
	 	 	 	 	 	 	 	 	 
	Jeff Quiram	 	 	 	Name:	 	 	 	 
	President & CEO	 	 	 	Title:	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Address:	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Tax ID No:	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Contact Name:	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Tel:	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Name in which book-entry should be made (if different):
	 

	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	Number of Shares

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]